Cargando…

Adult Acute Lymphoblastic Leukemia: Limitations of Intensification of Therapy in a Developing Country

PURPOSE: Limited data exist on intensifying chemotherapy regimens in the treatment of adult acute lymphoblastic leukemia (ALL) outside the setting of a clinical trial. MATERIALS AND METHODS: Retrospectively, data from 507 consecutive adults (age ≥ 15 years) with a diagnosis of ALL treated at our cen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jain, Punit, Korula, Anu, Deshpande, Prashant, PN, Nisham, Abu Alex, Ansu, Abraham, Aby, Srivastava, Alok, Janet, Nancy Beryl, Lakshmi, Kavitha M., Balasubramanian, Poonkuzhali, George, Biju, Mathews, Vikram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2018
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371642/ https://www.ncbi.nlm.nih.gov/pubmed/30222028 http://dx.doi.org/10.1200/JGO.17.00014

Ejemplares similares

Allogeneic Stem Cell Transplant for Acute Myeloid Leukemia: Evolution of an Effective Strategy in India
por: Ganapule, Abhijeet, et al.
Publicado: (2017)

Acute myeloid leukaemia: challenges and real world data from India
por: Philip, Chepsy, et al.
Publicado: (2015)

Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis
por: Alex, Ansu Abu, et al.
Publicado: (2018)

Outcome of iron reduction therapy in ex-thalassemics
por: Aboobacker, Fouzia N., et al.
Publicado: (2021)

NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy
por: Pai, Aswin Anand, et al.
Publicado: (2021)

A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide
por: Kulkarni, Uday, et al.
Publicado: (2020)

Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance
por: Chendamarai, Ezhilarasi, et al.
Publicado: (2015)

Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients
por: Rajamani, Bharathi M., et al.
Publicado: (2020)

Fludarabine-Based Low-Intensity Conditioning for Fanconi Anemia is Associated with Good Outcomes in Aplastic Anemia but not in MDS - a Single-Center Experience
por: Chattopadhyay, Sohini, et al.
Publicado: (2023)

Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia
por: Ganesan, Saravanan, et al.
Publicado: (2019)

Mutation profile in BCR-ABL1-negative myeloproliferative neoplasms: A single-center experience from India
por: Maddali, Madhavi, et al.
Publicado: (2021)

Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation
por: Balakrishnan, Balaji, et al.
Publicado: (2020)

Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts
por: Mathews, Vikram, et al.
Publicado: (2013)

Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia
por: Kulkarni, Uday, et al.
Publicado: (2023)

A rapid & sensitive liquid chromatography- tandem mass spectrometry method for the quantitation of busulfan levels in plasma & application for routine therapeutic monitoring in haematopoietic stem cell transplantation
por: Desire, Salamun, et al.
Publicado: (2013)

Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens
por: Fouzia, N. A., et al.
Publicado: (2020)

BK Polyomavirus Hemorrhagic Cystitis in Hematopoietic Cell Transplant Recipients
por: Lionel, Sharon Anbumalar, et al.
Publicado: (2022)

Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
por: Balasundaram, Nithya, et al.
Publicado: (2022)

Peripheral T cell lymphoma: Clinico-pathological characteristics & outcome from a tertiary care centre in south India
por: Nemani, Sandeep, et al.
Publicado: (2018)

Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia
por: Kulkarni, Uday P., et al.
Publicado: (2022)

Intracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse
por: Kulkarni, Uday Prakash, et al.
Publicado: (2023)

Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 Illness: A Phase II B Open Labelled Randomized Controlled Trial
por: George, Biju, et al.
Publicado: (2022)

Hematopoietic Stem Cell Transplantation is a cost-effective alternative to enzyme replacement therapy in Gaucher Disease
por: Aboobacker, Fouzia N, et al.
Publicado: (2022)

Speckle tracking echocardiography-derived left ventricular global longitudinal strain in ex-thalassaemics
por: Paul, Amal, et al.
Publicado: (2023)

Cytogenetic profile of 1791 adult acute myeloid leukemia in India
por: Srivastava, Vivi M., et al.
Publicado: (2023)

Hyperacute Graft-Versus-Host Disease of the Skin following Allogeneic Stem Cell Transplantation: A Paediatric Case Series
por: Mahabal, Gauri D., et al.
Publicado: (2023)

Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges
por: Balakrishnan, Balaji, et al.
Publicado: (2023)

Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation
por: Balakrishnan, Balaji, et al.
Publicado: (2023)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy
por: Sathya Kumar, Abi Manesh, et al.
Publicado: (2023)

A personalized approach to acute myeloid leukemia therapy: current options
por: Illangeswaran, Raveen Stephen Stallon, et al.
Publicado: (2019)

Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2
por: Karathedath, Sreeja, et al.
Publicado: (2017)

Management of B-cell lineage acute lymphoblastic leukemia: expert opinion from an Indian panel via Delphi consensus method
por: Mathews, Vikram, et al.
Publicado: (2023)

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
por: Rajamani, Bharathi M., et al.
Publicado: (2023)

Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E., et al.
Publicado: (2018)

Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E, et al.
Publicado: (2017)

Leukocyte Derived Chemotaxin 2 (ALECT2) Amyloidosis
por: Kulkarni, Uday, et al.
Publicado: (2015)

Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysis
por: Joshi, Gaurav, et al.
Publicado: (2023)

Mesenchymal stromal stem cell therapy in advanced interstitial lung disease - Anaphylaxis and short-term follow-up
por: Thangakunam, Balamugesh, et al.
Publicado: (2015)

Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells
por: Bagchi, Abhirup, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_36asqe5h4mrltb6jq29l7efphc